PI
GPCR icon

PEAK6 Investments’s Structure Therapeutics GPCR Stock Holding History

PEAK6 Investments’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$458K Hold
10,445
– – ﹤0.01% 2367
2024
Q2 		$410K Buy
+10,445
New +$429K ﹤0.01% 2361

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

PEAK6 Investments's GPCR Position: Q3 2024 in Review

PEAK6 Investments held its Structure Therapeutics (GPCR) position steady in Q3 2024 at 10,445 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

PEAK6 Investments first reported a position in GPCR in Q2 2024 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold GPCR as of Q3 2024.

  • PEAK6 Investments held 10,445 shares of Structure Therapeutics worth $458K as of Q3 2024.
  • PEAK6 Investments left its Structure Therapeutics share count unchanged in Q3 2024.
  • Structure Therapeutics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2367 holding.
  • PEAK6 Investments first reported a position in Structure Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 160 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.